Login / Signup

What is the optimum post treatment surveillance imaging protocol for low-grade appendiceal mucinous neoplasms and pseudomyxoma peritoneii?

Philip J DempseyJack W PowerAndrew H YatesLorena Martín-RománJohn J AirdJürgen MulsowHelen M FenlonCarmel G Cronin
Published in: The British journal of radiology (2024)
Appendiceal mucinous neoplasms are rare and can be associated with the development of disseminated peritoneal disease known as pseudomyxoma peritonei (PMP). Mucinous tumours identified on appendicectomy are therefore followed up to assess for recurrence and the development of PMP. In addition, individuals who initially present with PMP and are treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) are followed up to assess for recurrence. However, despite the concerted efforts of multiple expert groups, the optimal imaging follow-up protocol is yet to be established. The purpose of this article is to review the available evidence for imaging surveillance in these populations to identify the optimum post-resection imaging follow-up protocol.
Keyphrases
  • low grade
  • high grade
  • high resolution
  • randomized controlled trial
  • public health
  • squamous cell carcinoma
  • free survival
  • fluorescence imaging
  • coronary artery disease
  • newly diagnosed
  • rectal cancer
  • combination therapy